Influence of nitrovasodilators and endothelin‐1 on rheology of human blood in vitro

[1]  N. Uyesaka,et al.  Endothelin-1 improves the impaired filterability of red blood cells through the activation of protein kinase C. , 1999, The Japanese journal of physiology.

[2]  D. Hayoz,et al.  Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[3]  R. Marfella,et al.  Effects of Perindopril and Carvedilol on Endothelium-Dependent Vascular Functions in Patients With Diabetes and Hypertension , 1998, Diabetes Care.

[4]  D. Cheek,et al.  Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations. , 1998, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[5]  J. Gajewska,et al.  Antioxidant defence of red blood cells and plasma in stored human blood. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[6]  J P Cooke,et al.  Nitric oxide synthase: role in the genesis of vascular disease. , 1997, Annual review of medicine.

[7]  Jesse D. Roberts,et al.  Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn , 1997 .

[8]  R. Marfella,et al.  The vascular effects of L-Arginine in humans. The role of endogenous insulin. , 1997, The Journal of clinical investigation.

[9]  P. Vanhoutte,et al.  Vascular endothelium: vasoactive mediators. , 1996, Progress in cardiovascular diseases.

[10]  K. Schrör,et al.  Biotransformation of glyceryl trinitrate by blood platelets as compared to vascular smooth muscle cells. , 1996, European journal of pharmacology.

[11]  J. Abrams,et al.  Beneficial actions of nitrates in cardiovascular disease. , 1996, The American journal of cardiology.

[12]  B. Winkelmann,et al.  Clinical Pharmacokinetics of Molsidomine , 1996, Clinical pharmacokinetics.

[13]  S. Izumo,et al.  Control of endothelial cell gene expression by flow. , 1995, Journal of biomechanics.

[14]  R. Marfella,et al.  Abnormal Rheologic Effects of Glyceryl Trinitrate in Patients with Non-Insulin-Dependent Diabetes Mellitus and Reversal by Antioxidants , 1995, Annals of Internal Medicine.

[15]  I. Gwynn,et al.  Backscattered electron imaging of the undersurface of resin‐embedded cells by field‐emission scanning electron microscopy , 1995, Journal of microscopy.

[16]  Carl Nathan,et al.  Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.

[17]  M. Marletta,et al.  Nitric oxide synthase: Aspects concerning structure and catalysis , 1994, Cell.

[18]  B. Bennett,et al.  Biotransformation of organic nitrates and vascular smooth muscle cell function. , 1994, Trends in pharmacological sciences.

[19]  G. Hedenstierna,et al.  Prolonged bleeding time during nitric oxide inhalation in the rabbit. , 1994, Acta physiologica Scandinavica.

[20]  C. Caramelo,et al.  Effects of nitric oxide on red blood cells: changes in erythrocyte resistance to hypotonic hemolysis and potassium efflux by experimental maneuvers that decrease nitric oxide. , 1994, Biochemical and biophysical research communications.

[21]  S. Rimar,et al.  Selective Pulmonary Vasodilation by Inhaled Nitric Oxide Is Due to Hemoglobin Inactivation , 1993, Circulation.

[22]  W. Zijlstra,et al.  Rapid multicomponent analysis of hemoglobin derivatives for controlled antidotal use of methemoglobin-forming agents in cyanide poisoning. , 1993, Clinical chemistry.

[23]  D. Harrison,et al.  The Nitrovasodilators New Ideas About Old Drugs , 1993, Circulation.

[24]  R. Gryglewski,et al.  Nitric oxide from polymorphonuclear leukocytes modulates red blood cell deformability in vitro. , 1993, European journal of pharmacology.

[25]  S. Archer,et al.  Measurement of nitric oxide in biological models , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  Å. Wennmalm,et al.  Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin , 1992, British journal of pharmacology.

[27]  T. Loscher.  Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system. , 1991 .

[28]  H. Fung,et al.  Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. , 1990, The Journal of pharmacology and experimental therapeutics.

[29]  C. Vesey,et al.  Decay of nitroprusside. I: In vitro. , 1990, British journal of anaesthesia.

[30]  R. Moreau,et al.  Nitrovasodilators and portal hypertension. , 1990, Journal of hepatology.

[31]  K. Imaizumi,et al.  A kinetic study on functional impairment of nitric oxide-exposed rat erythrocytes. , 1987, Environmental health perspectives.

[32]  J. Brien,et al.  Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate. , 1986, The Journal of pharmacology and experimental therapeutics.

[33]  S. Chien,et al.  Red cell rheology in stomatocyte-echinocyte transformation: roles of cell geometry and cell shape. , 1986, Blood.

[34]  T. Meinertz,et al.  Relationship between pharmacokinetics and pharmacodynamics of molsidomine and its metabolites in humans. , 1985, American heart journal.

[35]  J E Ferrell,et al.  Phosphoinositide metabolism and the morphology of human erythrocytes , 1984, The Journal of cell biology.

[36]  M. Sheetz,et al.  Equilibrium and kinetic effects of drugs on the shapes of human erythrocytes , 1976, The Journal of cell biology.

[37]  R. Polin,et al.  Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. , 1997, The New England journal of medicine.

[38]  T. Lüscher.  Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system. , 1991, European heart journal.

[39]  C. Vesey,et al.  Decay of nitroprusside. II: In vivo. , 1990, British journal of anaesthesia.

[40]  M. Feelisch,et al.  On the Mechanism of NO Release from Sydnonimines , 1989, Journal of cardiovascular pharmacology.

[41]  L. Benet,et al.  Incomplete and delayed bioavailability of sublingual nitroglycerin. , 1985, The American journal of cardiology.

[42]  S. Chien,et al.  Chapter 26 – Biophysical Behavior of Red Cells in Suspensions , 1975 .

[43]  M. Bessis,et al.  Red cell shapes. An illustrated classification and its rationale. , 1972, Nouvelle revue francaise d'hematologie.